Neurology English Podcast

Lynn
  • 0.0 (0)
  • Medicine
  • Updated Semiweekly

A podcast for learners of neurology and neurology-related English, explaining key papers and hot topics in simple English.

Episodes

  1. May 19

    Conversation 5 | Gait Examination

    What you will learn This conversation introduces common abnormal gait patterns and their associated neurological diseases. Key words Sensory ataxia. Cerebellar ataxia. Spastic gait. Scissoring gait. Parkinsonian gait. Steppage gait. Intermittent claudication. Waddling gait. Source Clinical neurological examination and standard clinical practice. Note This episode is for educational purposes only. This is a practice conversation, not a real clinical interaction.

    6 min

  2. May 16

    Conversation 4 | Reflex Examination

    What you will learn This conversation introduces how to perform a basic reflex examination, including deep tendon reflexes, the Jendrassik maneuver, and the Babinski reflex. Key words Jaw jerk reflex. Biceps reflex. Patellar tendon reflex. Jendrassik maneuver. Babinski reflex. Source Clinical neurological examination and standard clinical practice. Note This episode is for educational purposes only. This is a practice conversation, not a real clinical interaction.

    5 min

  3. May 15

    Conversation 3 | Sensory Examination

    What you will learn This conversation introduces how to askabout numbness and how to perform a basic sensory examination. Key words Numbness. Anesthesia. Dysesthesia. Pain andtemperature sensation. Joint position sense. Vibration sense. Source Clinical neurological examination andstandard clinical practice. Note This episode is for educational purposesonly. This is a practice conversation, not a real clinical interaction.

    4 min

  4. Apr 21

    Conversation 2 | Manual Muscle Testing

    What you will learn This conversation practices manual muscle testing using simple and clear English commands for neurological examination. Key words Neck flexors, Neck extensors, Deltoid, Biceps brachii, Triceps brachii, Wrist extensors, Wrist flexors, Pinch, Abductor pollicis brevis, First dorsal interosseous, Abductor digiti minimi, Flexor digitorum profundus, Iliopsoas, Rectus femoris, Hamstrings, Tibialis anterior, Gastrocnemius Source Clinical neurological examination (standard practice) Note This conversation is for educational purposes only.

    4 min

  5. Apr 19

    Conversation 1 | Cranial Nerve Examination

    What you will learn This conversation introduces a step-by-step cranial nerve examination and helps you practice simple and practical English commands used in neurological exams. Key words Olfactory nerve. Optic nerve. Oculomotor nerve. Trochlear nerve. Trigeminal nerve. Abducens nerve. Facial nerve. Vestibulocochlear nerve. Glossopharyngeal nerve. Vagus nerve. Accessory nerve. Hypoglossal nerve. Source Clinical neurological examination (standard clinical practice). Note This conversation is for educational purposes only.

    4 min

  6. Apr 10

    Episode 7 | Cancer-Associated Stroke | Post-Treatment D-Dimer and Short-Term Outcomes

    What you will learn This episode reviews a multicenter retrospective study on cancer-associated stroke and explains why post-treatment plasma D-dimer levels, rather than pre-treatment levels, are independently associated with poor short-term outcomes and mortality.   Key words Cancer-associated stroke. Hypercoagulability. Recurrent. Cumulative. Mortality rate. Adjusted odds ratio. Anticoagulation therapy.   Source Post-Treatment Plasma D-Dimer Levels Are Associated With Short-Term Outcomes in Patients With Cancer-Associated Stroke. Front. Neurol.2022;13:868137. DOI:10.3389/fneur.2022.868137   Note This episode isfor educational purposes only. This is a summary and commentary, not theoriginal article.   Episode 7, Stroke 1.

    3 min

  7. Mar 31

    Episode 6 | CIDP | Corticosteroids in CIDP

    What you will learn This episode reviews a multicentre retrospective study of corticosteroidtreatment in CIDP and explains that daily prednisolone, pulsed dexamethasone,and pulsed intravenous methylprednisolone showed broadly similar efficacy andsafety outcomes. Key wordsPulsed dexamethasone.Pulsed intravenous methylprednisolone.Remission rates.Cumulative steroid dose.Responder. Sourcevan Lieverloo GGA, Peric S, Doneddu PE, et al. Corticosteroids in chronicinflammatory demyelinating polyneuropathy: A retrospective, multicentre study,comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, andpulsed intravenous methylprednisolone. J Neurol. 2018;265:2052–2059. DOI:10.1007/s00415-018-8948-y. NoteThis episode is for educational purposes only. This is a summary andcommentary, not the original article. Episode 6, CIDP 3.

    3 min

  8. Mar 29

    Episode 5 | CIDP | Very High Dose Immunoglobulin Treatment in CIDP

    What you will learnThis episode reviews a multicentre UK study on very high dose immunoglobulin treatment in CIDP and explains why dose escalation may not always be the best option in patients with a poor response.   Key wordsPre-treatment disability.Maximal improvement.Thromboembolic complications.Suboptimal response. dose escalation.  SourceVery High Dose Immunoglobulin Treatment for Chronic Inflammatory DemyelinatingPolyneuropathy: A Multicentre UK Study.Eur J Neurol. 2025;32(11):e70429.DOI: 10.1111/ene.70429. NoteThis episode is for educational purposes only. This is a summary and commentary, not the original article.Episode 5, CIDP 2.

    3 min

  9. Mar 25

    Episode 4| CIDP | Determinants of Long-Term Disability in CIDP

    What you will learnThis episode reviews a multicenter study on chronic inflammatory demyelinating polyradiculoneuropathy, or CIDP, and explains how early treatment may be a key modifiable factor in reducing long-term disability. Key wordsdeterminants, therapeutic factors, long-term disability, univariate and multivariate linear regression analyses, modifiable factor SourceDeterminants of long-term disability in chronic inflammatory demyelinating polyradiculoneuropathy: A multicenter Korea/UK study of 144 patients.Eur J Neurol. 2025;32(1):e16575.DOI: 10.1111/ene.16575 NoteThis episode is for educational purposes only. This is a summary and commentary, not the original article. Episode 4, CIDP 1

    3 min

  10. Mar 22

    Episode 3 | Dementia | Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke

    What you will learnA short review of a serious case report involving lecanemab, t-PA, and multiple cerebral hemorrhages after acute ischemic stroke.Key words cerebral hemorrhage, t-PA, homozygous, gaze preference, administer, intraparenchymal, cerebral amyloid angiopathySourceMultiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke.N Engl J Med. 2023;388:478-479.DOI: 10.1056/NEJMc2215148NoteThis episode is for educational purposes only. This is a summary and commentary, not the original article. Episode 3, dementia 3

    2 min

  11. Mar 21

    Episode 2 | Dementia | Donanemab in Early Symptomatic Alzheimer’s Disease

    What you will learnA short review of the TRAILBLAZER-ALZ 2 trial and how donanemab showed clinical benefit in early symptomatic Alzheimer’s disease. Key words early symptomatic Alzheimer’s diseaseiADRSleast-squares mean changeCDR-SBamyloid plaqueARIA Short summaryThis episode reviews the TRAILBLAZER-ALZ 2 trial, published in JAMA in 2023. Donanemab slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease. Unlike Clarity AD, the pivotal trial of lecanemab, this study incorporated tau pathology into the trial design. The results supported the clinical benefit of anti-amyloid therapy, while adverse events such as amyloid-related imaging abnormalities remained important. Source Mintun MA, Lo AC, Duggan Evans C, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023. DOI: 10.1001/jama.2023.13239 Note This episode is for educational purposes only. This is a summary and commentary, not the original article. Episode 2. Dementia 2

    3 min

  12. Mar 19

    Episode 1 | Dementia | Lecanemab in Early Alzheimer’s Disease

    What you will learn A short review of a key paper in neurology, explained in simple English. Key words monoclonal antibody protofibril cognitive decline CDR-SB ADAS-Cog14 adjusted mean change adverse events Short summary Lecanemab slowed cognitive and functional decline in early Alzheimer’s disease over 18 months. Clinical outcomes such as CDR-SB and ADAS-Cog14 also favored lecanemab, although adverse events remained important. Source van Dyck CH, et al. Lecanemab in Early Alzheimer’s Disease. N Engl J Med. 2023. DOI: 10.1056/NEJMoa2212948 Note This episode is for educational purposes only. This is a summary and commentary, not the original article. Episode 1, Dementia 1

    3 min
  • 12 Episodes

About

A podcast for learners of neurology and neurology-related English, explaining key papers and hot topics in simple English.

Information